This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Dec. 4, 2012


Standards for patient-friendly container labels released
American Society of Health-System Pharmacists    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The United States Pharmacopeial Convention recently unveiled universal standards for prescription drug container labels that are intended to make it easier for patients to take their medications as prescribed. The standards emphasize patient-friendly elements such as prominent placement of the most important information and the use of clear, simplified language and explicit instructions. The standards also address legibility by requiring high-contrast print, a large font size for critical information and prudent use of white space. More

 Area and Association News

Register today for the AzPA Psychiatric Certificate Program
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Assessing, Monitoring, and Managing Patients with Psychiatric Disorders: Comprehensive Medication Therapy Management to Optimize Pharmaceutical Care Learn more.

Inaugural Southwest Pharmacy Symposium
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Become a Pharmacy A.C.E. — Advocate, Communicate, Educate. Saturday, Jan. 26, 2013. Learn more.

NCPA: Gallup Poll Finds Public Confidence in Pharmacists at Record High
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA, issued a statement in response to the annual Gallup survey regarding professional honesty and ethics. More

Shop and support AzPA
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Will you be shopping online at this holiday season? Bookmark the AzPA Amazon Affiliates page and a portion of your purchases will be donated to AzPA.

Holiday shopping is upon us
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Remember to purchase your gift cards through AzPA and support pharmacy education in Arizona. Learn more.

Not an AzPA member? Join today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry. More

 Pharmacy Updates

Walgreens program employs pharmacists to reduce hospital readmissions
Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Walgreens recently announced a new transition of care program featuring pharmacists in a key role that aims to reduce readmission rates along with overall healthcare costs, while improving patient health outcomes and medication adherence. The program, called WellTransitions, is being rolled out as hospitals face pressure to keep readmission rates for Medicare patients low or pay penalties, which went into effect on Oct. 1. As part of the program, Walgreens pharmacists work with hospital staff to oversee the medication regimens of discharged patients. More

Medication adherence increased by automated phone and mail notices
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Patients newly prescribed a cholesterol-lowering medication were more likely to pick it up from the pharmacy if they received automated phone and mail reminders, according to a study published in the Archives of Internal Medicine. This is one of a few published studies to examine strategies for reducing primary nonadherence, which occurs when patients do not pick up new prescriptions. More

Pharmacy Insider video series
Enhance your coordination and communication with community physicians

This is your behind-the-scenes look at helping to increase access to adult vaccines. In this segment, Dennis offers tips on reaching out to local providers, creating collaborative practice agreements, and engaging in follow-up conversations with physicians.

Watch Dennis' video today and remember to check back for upcoming videos.
The #1 Selling Brain Health Supplement in Drug Stores Nationally.
Supports a Healthier Brain, Sharper Mind & Clearer Thinking*
As we age, we lose proteins that support our brain.* Prevagen® supplements these proteins during the natural process of aging.* Prevagen® (apoaequorin) is clinically shown to help with mild memory problems associated with aging.* Available over the counter. Visit
Harness the Rejuvenation Power of Your Own Stem Cells
Important benefits of Stem Cell 100™
  • Powerful anti-aging properties
  • Provides immune support
  • Promotes younger looking skin
  • Supports cardiovascular health
  • Renews health and vitality

  •  In the News

    Chronically ill kids more vulnerable to hospital medical errors
    Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Even after accounting for confounding variables such as disease severity and length of stay, pediatric inpatients with chronic conditions are significantly more likely to experience medical errors, according to the results of a study. More

    North Dakota Pharmacy Board bans additional synthetic substances
    The Bismarck Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    John Snyder is a big man who looks like he could hold his own in a brawl. But relating what happened when his 13-year-old daughter had a bad reaction to a synthetic drug in October almost brought him to tears in front of the North Dakota Board of Pharmacy. The board recently held a public meeting at the North Dakota State Capitol to hear testimony on whether it should add numerous substances being used as alternatives to drugs to a list of banned substances. The board unanimously accepted the proposed rules as presented by the North Dakota Attorney General's Office. The synthetic substances will be illegal as soon as the rules are published with the Legislative Council. More

     Medication Updates

    Antidepressants may lead to fewer seizures in people with epilepsy
    HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Besides helping to boost mood, antidepressants may also reduce seizure frequency for people with epilepsy, a new study suggests. The study, to be presented at the annual meeting of the American Epilepsy Society in San Diego, included patients who were prescribed one of two types of antidepressants — selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors. These types include drugs such as Celexa, Paxil, Prozac and Zoloft, among others. More

    Increased mortality with digoxin in AF
    Medscape News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    The use of digoxin in patients with atrial fibrillation is being called into question, with the publication of a new study suggesting it is associated with a significant increase in all-cause mortality. The study, a propensity-adjusted analysis of the AFFIRM trial that controlled for multiple comorbidities, was published online on Nov. 27 in the European Heart Journal. It found an overall 41 percent increase in all-cause mortality in patients taking digoxin versus those not taking digoxin. The increase in all-cause mortality was consistently observed in men and women and in patients with and without underlying heart failure. More

    Common diabetes drug shows promise as ovarian cancer treatment
    HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Ovarian cancer may join a growing list of malignancies that seem to be slowed by a commonly prescribed diabetes drug. Ovarian cancer patients who were taking metformin at the time of their diagnosis survived longer than patients who weren't on the drug, a new study by Mayo Clinic researchers shows. More

    Oral contraceptives may increase VTE risk in women with PCOS
    Medscape News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Oral contraceptives, largely considered the most effective treatment to relieve symptoms for women with polycystic ovary syndrome, might place patients at elevated risk for venous thromboembolism events, according a population-based study. Risk for nonfatal VTE was two times greater among 43,506 women with a diagnosis of PCOS who were receiving combined hormonal contraceptives compared with 43,506 matched control women who were taking contraceptives but did not have PCOS. More

    AzPA Pharmacy Flash
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Danielle Wegert, Content Editor, 469.420.2696   
    Contribute news

    Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

    This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
    Recent issues
    Dec. 4, 2012
    Nov. 27, 2012
    Nov. 20, 2012
    Nov. 13, 2012

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063